DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Cantor Fitzgerald Initiates Coverage On Provention Bio with Overweight Rating, Announces $25 Price Target

Cantor Fitzgerald analyst Alethia Young initiates coverage on Provention Bio (NASDAQ:PRVB) with a Overweight rating and a $25 price target.

Benzinga · 01/24/2020 13:46

Cantor Fitzgerald analyst Alethia Young initiates coverage on Provention Bio (NASDAQ:PRVB) with a Overweight rating and a $25 price target.